# Vasopressin in 0.9% Sodium Chloride

NDC: 0338-9647
Generic name: Vasopressin in 0.9% Sodium Chloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20230929

FDA application: NDA217569

## Active ingredients

- VASOPRESSIN: 40 [USP'U]/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-9647"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-9647
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5b2c367-6b7e-40be-a296-c4632f3e783f